p-cd19cd20-allo1
p-cd19cd20-allo1: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Poseida Therapeutics, Inc. (PSTX) | Phase 1 |
Clinical Trials (1)
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-CD19CD20-ALLO1 in Subjects With Selected Relapsed/Refractory B Cell Malignancies
Frequently asked questions
Who is developing p-cd19cd20-allo1?
p-cd19cd20-allo1 is being developed by Poseida Therapeutics, Inc..
How many clinical trials involve p-cd19cd20-allo1?
BioSniper tracks 1 clinical trial involving p-cd19cd20-allo1.
Get deeper analysis on p-cd19cd20-allo1
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis